{"id":983924,"date":"2026-07-23T00:12:32","date_gmt":"2026-07-23T04:12:32","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-holdings-corp-reports-fiscal-2026-results-revenue-up-46-as-the-company-completes-its-pivot-to-bio-native-ai-infrastructure\/"},"modified":"2026-07-23T00:12:32","modified_gmt":"2026-07-23T04:12:32","slug":"mindwalk-holdings-corp-reports-fiscal-2026-results-revenue-up-46-as-the-company-completes-its-pivot-to-bio-native-ai-infrastructure","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mindwalk-holdings-corp-reports-fiscal-2026-results-revenue-up-46-as-the-company-completes-its-pivot-to-bio-native-ai-infrastructure\/","title":{"rendered":"MindWalk Holdings Corp. Reports Fiscal 2026 Results: Revenue Up 46% as the Company Completes Its Pivot to Bio-Native AI Infrastructure"},"content":{"rendered":"

<\/p>\n

MindWalk Holdings Corp. Reports Fiscal 2026 Results: Revenue Up 46% as the Company Completes Its Pivot to Bio-Native AI Infrastructure<\/b><\/p>\n

Full-year revenue rose 46% to $15.6 million with gross margin expanding to 59%; net loss narrowed by more than half as MindWalk sharpened its focus on the BioIntelligence infrastructure powering AI drug discovery.<\/i><\/p>\n

AUSTIN, Texas–(BUSINESS WIRE<\/a>)–
\nMindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today reported financial results for the fiscal year ended April 30, 2026. All figures are in Canadian dollars unless otherwise noted.<\/p>\n

\nFiscal 2026 was the year MindWalk completed its transition from building its technology to deploying it. Revenue grew 46% year over year, gross margin expanded, the net loss narrowed by more than half, and the Company divested a non-core business to concentrate on the BioIntelligence infrastructure that life sciences AI and agentic AI require.<\/p>\n

“<\/i>We are not an AI company that discovered biology. We are a biology company that built AI on top of more than 40 years of biology heritage, and fiscal 2026 is the year the market began to see it in our results,” <\/i>said Dr. Jennifer Bath, President and Chief Executive Officer of MindWalk. “Revenue grew 46%, margins expanded, and we simplified the business around the layer where enterprise AI value accrues. HYFT Technology powers ReefIQ, the biological context layer for life sciences, and LensAI is in contracted, recurring arrangements with life sciences customers today. Value compounds in that layer, not in any individual model that runs on top of it.”<\/i><\/p>\n

Fiscal 2026 financial highlights<\/b><\/p>\n

\nYear ended April 30 (in thousands of Canadian dollars, except per-share data). Preliminary and subject to filing of the Annual Report on Form 20-F.<\/p>\n\n\n\n\n\n\n\n\n\n\n
\n

Metric<\/b><\/p>\n<\/td>\n

\n

FY2026<\/b><\/p>\n<\/td>\n

\n

FY2025<\/b><\/p>\n<\/td>\n

\n

Change<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

Revenue<\/b><\/p>\n<\/td>\n

\n

\n15,558<\/p>\n<\/td>\n

\n

\n10,626<\/p>\n<\/td>\n

\n

\n+46%<\/p>\n<\/td>\n<\/tr>\n

\n

Gross profit<\/b><\/p>\n<\/td>\n

\n

\n9,148<\/p>\n<\/td>\n

\n

\n5,731<\/p>\n<\/td>\n

\n

\n+60%<\/p>\n<\/td>\n<\/tr>\n

\n

Gross margin<\/b><\/p>\n<\/td>\n

\n

\n58.8%<\/p>\n<\/td>\n

\n

\n53.9%<\/p>\n<\/td>\n

\n

\n+4.9 pts<\/p>\n<\/td>\n<\/tr>\n

\n

Total operating expenses<\/b><\/p>\n<\/td>\n

\n

\n24,085<\/p>\n<\/td>\n

\n

\n42,639<\/p>\n<\/td>\n

\n

\n-44%<\/p>\n<\/td>\n<\/tr>\n

\n

Net loss, continuing operations<\/b><\/p>\n<\/td>\n

\n

\n(15,102)<\/p>\n<\/td>\n

\n

\n(33,147)<\/p>\n<\/td>\n

\n

\n+54%<\/p>\n<\/td>\n<\/tr>\n

\n

Net loss for the year<\/b><\/p>\n<\/td>\n

\n

\n(13,949)<\/p>\n<\/td>\n

\n

\n(30,234)<\/p>\n<\/td>\n

\n

\n+54%<\/p>\n<\/td>\n<\/tr>\n

\n

Loss per share, continuing<\/b><\/p>\n<\/td>\n

\n

\n(0.33)<\/p>\n<\/td>\n

\n

\n(0.99)<\/p>\n<\/td>\n

\n

\n+67%<\/p>\n<\/td>\n<\/tr>\n

\n

Cash and restricted cash<\/b><\/p>\n<\/td>\n

\n

\n11,474<\/p>\n<\/td>\n

\n

\n10,791<\/p>\n<\/td>\n

\n

\n+6%<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nOperating-expense decrease primarily reflects the non-recurrence of approximately $22.7 million of prior-year non-cash amortization and impairment of intangible assets and goodwill.<\/p>\n

Fiscal 2026 and recent business highlights<\/b><\/p>\n